Related Experiment Videos
Acute hypertensive crisis in pregnancy
1Department of Obstetrics and Gynecology, University of California-Davis, Sacramento.
The Medical Clinics of North America
|May 1, 1989
Summary
Severe pre-eclampsia presents unique challenges for hypertensive emergency treatment. Hydralazine is the preferred agent, but complex cases may require individualized therapy with hemodynamic monitoring.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Pharmacology
Background:
- Severe pre-eclampsia involves acute afterload increase, potentially leading to uncompensated states.
- Managing hypertension in pregnancy is complex due to fetal and uteroplacental blood flow concerns.
- Individualized antihypertensive therapy is ideal but often limited by safety considerations for the fetus.
Purpose of the Study:
- To outline the challenges and considerations in managing hypertensive emergencies during pregnancy.
- To identify the preferred antihypertensive agent for acute hypertensive emergencies in pregnancy.
- To discuss alternative agents and the role of hemodynamic monitoring in complicated cases.
Main Methods:
- Review of current understanding of severe pre-eclampsia pathophysiology.
- Analysis of antihypertensive agent choices in pregnant patients.
- Consideration of fetal safety and uteroplacental blood flow effects.
Main Results:
- Hydralazine is identified as the primary choice for acute hypertensive emergencies in pregnancy.
- Individualized therapy is necessary due to diverse patient presentations.
- Sodium nitroprusside and nitroglycerin are options for complicated or resistant cases.
Conclusions:
- Hydralazine is the recommended agent for acute hypertensive emergencies in pregnancy.
- Complicated cases necessitate careful consideration of alternative agents and hemodynamic monitoring.
- Tailoring therapy to individual hemodynamic profiles ensures optimal safety and efficacy.